{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:05:36Z","timestamp":1786118736067,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1097\/mnm.0b013e32801a3e90","type":"journal-article","created":{"date-parts":[[2007,2,26]],"date-time":"2007-02-26T04:06:36Z","timestamp":1172462796000},"page":"267-272","source":"Crossref","is-referenced-by-count":10,"title":["Influence of CA 15-3 blood level and doubling time on diagnostic performances of 18F-FDG PET in breast cancer patients with occult recurrence"],"prefix":"10.1097","volume":"28","author":[{"given":"Nicolas","family":"Aide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Huchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Switsers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Heutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Delozier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Hardouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bardet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210212","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/172460080201700403","article-title":"Prognostic value of CA 15.3 kinetics for metastatic breast cancer","volume":"17","author":"De La Lande","year":"2002","journal-title":"Int J Biol Markers"},{"key":"R2-7-20210212","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/ctrv.1999.0151","article-title":"Tumour marker measurements in the diagnosis and monitoring of breast cancer","volume":"26","author":"Cheung","year":"2000","journal-title":"Cancer Treat Rev"},{"key":"R3-7-20210212","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/clinchem\/45.10.1695","article-title":"Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring","volume":"45","author":"Bidart","year":"1999","journal-title":"Clin Chem"},{"key":"R4-7-20210212","first-page":"1249","article-title":"18FDG PET in oncology: the best and the worst [Review]","volume":"28","author":"Belhocine","year":"2006","journal-title":"Int J Oncol"},{"issue":"1","key":"R5-7-20210212","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1007\/s00259-004-1531-z","article-title":"FDG-PET for axillary lymph node staging in primary breast cancer","volume":"31","author":"Crippa","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"R6-7-20210212","first-page":"S125","article-title":"Advantages and limitations of FDG PET in the follow-up of breast cancer","volume":"31","author":"Lind","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R7-7-20210212","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/jjco\/hyf052","article-title":"Clinical impact of [(18)F]FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels: a preliminary report","volume":"32","author":"Liu","year":"2002","journal-title":"Jpn J Clin Oncol"},{"key":"R8-7-20210212","first-page":"113","article-title":"Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers","volume":"46","author":"Suarez","year":"2002","journal-title":"Q J Nucl Med"},{"key":"R9-7-20210212","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3816\/CBC.2001.n.026","article-title":"Detection of occult disease in breast cancer using fluorodeoxyglucose camera-based positron emission tomography","volume":"2","author":"Pecking","year":"2001","journal-title":"Clin Breast Cancer"},{"key":"R10-7-20210212","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00259-003-1348-1","article-title":"[18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management","volume":"31","author":"Grahek","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R11-7-20210212","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2000.18.20.3495","article-title":"Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations","volume":"18","author":"Avril","year":"2000","journal-title":"J Clin Oncol"},{"key":"R12-7-20210212","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/cncr.21696","article-title":"Critical analysis of prostate-specific antigen doubling time calculation methodology","volume":"106","author":"Svatek","year":"2006","journal-title":"Cancer"},{"key":"R13-7-20210212","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/cncr.22018","article-title":"Predictors of mortality after androgen-deprivation therapy in patients with rapidly rising prostate-specific antigen levels after local therapy for prostate cancer","volume":"107","author":"Rodrigues","year":"2006","journal-title":"Cancer"},{"key":"R14-7-20210212","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2006.01.053","article-title":"Predictors of mortality after prostate-specific antigen failure","volume":"65","author":"D'Amico","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006231-200704000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:27:24Z","timestamp":1786033644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006231-200704000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e32801a3e90","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}